Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Solve supply chain risks in chiral synthesis with this novel protonic acid catalyst. Achieve 98% ee and 96% yield in ruthenium-catalyzed reactions. Contact us for custom synthesis.
Discover copper-catalyzed indole synthesis with 74-90% yields, nitrogen protection, and 110°C mild conditions. Reduce R&D costs and supply chain risks for pharmaceutical intermediates.
Discover how Rh(III)-catalyzed tandem synthesis of 6-amino-5-acyl benzo[a]carbazole reduces production costs and improves yield for pharmaceutical intermediates.
Discover a novel palladium-catalyzed method for quinoline-4(1H)-ketone synthesis with high yield, broad substrate tolerance, and simplified post-treatment. Reduce production costs and supply chain risks for pharmaceutical intermediates.
Discover a cost-effective, palladium-free synthesis of Vismodegib with 99% purity. Eliminate anhydrous/oxygen-free requirements and reduce supply chain risks for your oncology projects.
Discover a cost-effective, high-yield method for indole ketone thioesters using sulfonyl chloride as sulfur source. Eliminate catalyst poisoning risks and streamline your API synthesis.
Solve high-cost, low-yield issues in tegrazan intermediate production. New route achieves ≥99% purity with simplified steps and 100kgs+ scale capability.
Solve supply chain risks with metal-free 5-trifluoromethyl triazole synthesis. 80%+ yields, no azides, scalable to 100MT. Contact for custom synthesis.
Reduce supply chain risks with metal-free deracemization process. 90%+ yield, 95% ee, and scalable production for chiral alcohol intermediates.
Solve capecitabine production challenges with non-toxic alkoxycarbonylation. Avoid phosgene, reduce EHS risks, and achieve >80% yields for stable supply chains.
Overcome synthesis challenges of trisubstituted allenes with mild reaction conditions, high functional group tolerance, and 70%+ yields. Reduce supply chain risks for API manufacturing.
Discover a one-step Pd-catalyzed method for 1,5-dihydro-2H-pyrrole-2-ketone with 70-92% yield. Reduce production costs and supply chain risks for pharmaceutical intermediates.
Solve heavy metal contamination in benzothiazole synthesis. Our CDMO expertise scales this visible light method with >99% purity and 98% yield for your API production.
Discover how metal-free, photo-catalyzed synthesis of perfluoroalkyl benzimidazoloisoquinolinones reduces costs and supply chain risks for pharmaceutical intermediates. Contact us for custom synthesis.
Discover how iodine-catalyzed metal-free synthesis of 3-arylthioimidazo[1,5-a]N-heterocycles solves transition metal contamination risks and improves yield for pharmaceutical intermediates.
Discover how copper-catalyzed benzofuran synthesis reduces heavy metal risks and production costs for pharmaceutical intermediates. Scale-ready solution for R&D and procurement teams.
Solve supply chain risks with this cost-effective, scalable trifluoromethyl chromonoquinoline synthesis. 99% purity, 100kgs-100MT production capacity. Contact for COA/MSDS.
Discover a cost-efficient, scalable synthesis method for furo[3,2-b]pyridine derivatives, eliminating precious metal use and reducing production costs for JAK1 inhibitor development.
Eliminate HCl gas handling and corrosion risks with EDC-NHS coupling. Achieve 92% yield and 99.7% purity for scalable betrixaban maleate production.
Solve low-yield pyranocoumarin synthesis challenges with metal-catalyzed routes. Achieve 74-98% yields, reduce environmental impact, and ensure supply chain stability for HIV/anti-estrogen drug development.